pharmacometrics in phase 3 – data integration and analysis to support dose and labeling for the nda
Published 3 years ago • 131 plays • Length 20:56Download video MP4
Download video MP3
Similar videos
-
27:42
pharmacometrics phase 2 proof-of-concept dose selection phase 3/marketing
-
28:51
pharmacometrics in phase 1: first in human and dose selection for phase 2
-
25:18
pharmacometrics post approval fulfillment of requirements label extension and life-cycle management
-
4:42
introduction to phase iii track with beth ludwig
-
1:03:33
pharmacometrics symposium: applied meta-analysis in drug development
-
9:48
prof joe standing - pharmacometrics: quantitative pharmacology
-
4:56
introduction to phase ii track with joel owen
-
7:43
introduction to fih/phase 1 track
-
58:45
best practices in clinical pharmacology gap analysis
-
14:09
population pharmacokinetic evaluation & missed-dose simulations eslicarbazepine acetate monotherapy
-
28:57
pre clinical track: ophthalmic clinical pharmacokinetic/pharmacodynamic prediction using pbpk model
-
1:12:39
strategic implementation of model-informed drug development (midd) for regulatory success
-
22:52
regulatory perspectives for reliable model informed drug development (midd)
-
2:02
pharmacoepidemiology at monash
-
1:05:36
project optimus – fda’s new dose optimization & selection paradigm in oncology drug development